SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
MOMENTA PHARMACEUTICALS
(NQNM:MNTA Last Sale: 31.64 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (MNTA : $31.64)
$3,722,111 million Market Cap at Market Close, July 1, 2022
Employs 105.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
675 West Kendall Street Research Report Earnings Snapshot - Last 11/05/18
Cambridge, MA 02142 Fact Sheet
Phone: (617) 491-9700 Financial Statements
Peer Comparison
Annual Reports

Peter Barrett, Chmn., Craig A. Wheeler, Pres./CEO, Richard P. Shea, CFO
Develops generic genetically engineered drugs. IPO at $6.50 June 21, 2004. Raised $34.8 million, selling 5.4 million shares, 22% of the outstanding. Lead Manager: SG Cowen Securities Corp. Reached an aggrement July 25, 2006 with Sandoz, the generics business of Switzerland-based Novartis AG, to pay $75 million for 4.7 million shares at $15.93, with Momenta also eligible for $188 million in additional payments if its milestone achievements are reached. The parties have had a similar partnership since November 2003 on the generic drug M-Enoxaparin, which is used to treat deep vein thrombosis and several cardiovascular conditions. Has another partnership with Massachusetts Institute of Technology for characterization and synthesis of sugars for the purpose of researching, developing, and commercializing products. Founded in 2001 as Mimeon, Inc.
Historical Charts    Technical Analysis
No Historical Data available for MNTA

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common MNTA $31.64 $31.64 0 .0 $29.4 $31.96 680,218 $29.4 $31.96 117,639,406
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex